What is the average price target for ADAPTHEALTH CORP (AHCO) stock?
14 analysts have analysed AHCO and the average price target is 13.13 USD. This implies a price increase of 3.73% is expected in the next year compared to the current price of 12.66.
NASDAQ:AHCO • US00653Q1022
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ADAPTHEALTH CORP (AHCO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-13 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-26 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-12 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-27 | Baird | Maintains | Outperform -> Outperform |
| 2025-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-26 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-13 | UBS | Maintains | Buy -> Buy |
| 2024-11-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-06 | UBS | Maintains | Buy -> Buy |
| 2024-11-06 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-28 | UBS | Maintains | Buy -> Buy |
| 2024-02-28 | Truist Securities | Maintains | Buy -> Buy |
| 2024-01-29 | UBS | Maintains | Buy -> Buy |
| 2023-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-08 | Truist Securities | Maintains | Buy -> Buy |
| 2023-11-08 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-10-11 | Truist Securities | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.2B 7.73% | 3.261B 1.90% | 3.245B -0.49% | 3.537B 9.00% | 3.782B 6.93% | 3.984B 5.34% | N/A | N/A | |
| EBITDA YoY % growth | 641.029M 18.36% | 670.844M 4.65% | 587.493M -12.42% | 710.38M 20.92% | 778.2M 9.55% | 817.71M 5.08% | N/A | N/A | |
| EBIT YoY % growth | 258.246M 35.63% | 305.51M 18.30% | 205.566M -32.71% | 282.81M 37.58% | 329.8M 16.62% | 336.56M 2.05% | 541.62M 60.93% | N/A | |
| Operating Margin | 8.07% | 9.37% | 6.34% | 8.00% | 8.72% | 8.45% | N/A | N/A | |
| EPS YoY % growth | -1.29 -596.15% | 0.60 146.51% | -0.78 -230.00% | 1.03 232.26% | 1.30 25.73% | 1.37 5.37% | 1.53 11.94% | 1.73 13.33% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 134.97% | 0.23 273.74% | 0.33 105.82% | 0.46 160.97% | 0.17 891.83% | 0.30 32.47% | 0.34 4.28% | 0.45 -2.41% | 0.18 5.88% | 0.44 46.59% | 0.45 30.69% | 0.52 15.04% |
| Revenue Q2Q % growth | 812.55M 4.46% | 857.06M 7.08% | 906.46M 10.50% | 961.02M 13.56% | 897.77M 10.49% | 930.02M 8.51% | 956.2M 5.49% | 1.013B 5.41% | 960.62M 7.00% | 1.003B 7.85% | 1.035B 8.24% | 1.082B 6.81% |
| EBITDA Q2Q % growth | 129.73M 5.80% | 169.41M -30.44% | 193.37M -44.60% | 217.91M -50.24% | 158.83M 22.43% | 192.99M 13.92% | 205.71M 6.38% | 229.09M 5.13% | 175.87M 10.73% | 223.23M 15.67% | 232M 12.78% | 247.44M 8.01% |
| EBIT Q2Q % growth | 26.616M -5.85% | 64.758M 13.96% | 84.122M 30.16% | 107.31M 91.49% | 49.422M 85.69% | 81.702M 26.17% | 90.018M 7.01% | 111.28M 3.70% | 59.364M 20.12% | 107.44M 31.50% | 108.76M 20.82% | 122.83M 10.38% |
All data in USD
14 analysts have analysed AHCO and the average price target is 13.13 USD. This implies a price increase of 3.73% is expected in the next year compared to the current price of 12.66.
ADAPTHEALTH CORP (AHCO) will report earnings on 2026-05-05, before the market open.
The consensus EPS estimate for the next earnings of ADAPTHEALTH CORP (AHCO) is 0.02 USD and the consensus revenue estimate is 812.55M USD.
The consensus rating for ADAPTHEALTH CORP (AHCO) is 81.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.